EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Booz Allen Hamilton Holding Corporation
BAH

BAH Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corporation · NYSE
Market Closed
75.90
▲ ⁦+0.29%⁩ (+0.22)
Market Cap$9.1B
Beta0.35
52w Low52w High
59.50110.55
Last Week
⁦+3.73%⁩
Last Month
⁦-3.40%⁩
Last 3 Months
⁦-9.70%⁩
Last Year
⁦-29.87%⁩
EL7 Factor Analysis
How we score this
Overall81
Excellent — top fifth of the marketContrarianF 4/9SafeBetter than 81% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
86
11.9x▲17.8xTop tier
▸
Growth
38
-7.3%▼7.1%Bottom tier
▸
Quality
93
17.5%▲4.5%Top tier
▸
Safety
57
3.0x▼2.6xAround median
▸
Capital Return
77
3.03%▲2.12%Top tier
▸
Momentum
32
-29.7%▼2.9%Bottom tier
▸
Sentiment
62
10▲3Around median
Fair Value
Current price$76
Analyst target · 6 analysts
$80
⁦+5%⁩
See it undervalued
Range ⁦$65–$140⁩
vs
DCF (estimate)
$141
⁦+86%⁩
Sees it clearly undervalued
⁦7.9⁩% discount · ⁦2⁩% growth
Bottom lineThe two methods broadly agree — estimate range ⁦$80–$141⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 6 analysts setting price target
$89.00
⁦+17.3%⁩
Current Price $75.90·Median $80.00
Low
$65.00
High
$140.00
Current price
$75.90
Average target
$89.00
Street summary

Stable Consensus with Wide Dispersion

The consensus price target remained stable at 89 over the last 7 days, despite the number of analysts increasing from 4 to 6 within a single day. Over 30 days, the consensus declined slightly from 89.71 to 89, a decrease of 0.79%, indicating limited softening rather than a sharp change in expectations. The current range is between 65 and 140, while the median is 80 versus a current price of 75.9, reflecting wide variation among analysts’ views.

As of 2026-09-11
Revisions momentum · 30d
⁦-0.8%⁩
Average rating
★ 2.86
Hold
Analyst coverage
⁦14 (+2)⁩
New coverage
Buy conviction
21%
Target dispersion
99%
Wide
Analyst ratings over time14 analysts rating
3
8
1
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months2.79 → 2.86
Recent analyst moves
  • = Reiterate2026-07-27
    UBS
    Neutral
  • = Reiterate2026-07-23
    Cantor Fitzgerald
    Overweight
  • = Reiterate2026-07-14
    Goldman Sachs
    Sell
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    11.92x
    5.69x45.54x
    Very cheap
  • Forward P/E
    11.82x
    4.57x36.58x
    Cheap
  • EV / EBITDA
    10.44x
    3.43x27.47x
    Cheap
  • FCF Yield
    12.2%
    -32.7%11.5%
    Exceptional
  • Revenue Growth YoY
    -7.3%
    -10.7%43.4%
    Weak
  • EPS Growth YoY
    -21.7%
    -128.3%132.7%
    Near median
  • Gross Margin
    53.0%
    8.6%54.6%
    Strong
  • ROIC
    17.5%
    -25.3%19.6%
    Strong
  • Net Debt / EBITDA
    2.98x
    0.55x4.37x
    Near median
  • Dividend Yield
    3.0%
    0.1%4.8%
    Moderate
  • Payout Ratio
    35.9%
    6.6%80.8%
    Moderate
  • Altman Z-Score
    3.64
    -5.667.97
    Above average
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-24 data

Company Overview

Booz Allen Hamilton provides technology services and products related to government missions, with two main portfolios: National Security and Civil. The company targets growth through cybersecurity, defense technologies, artificial intelligence, and edge computing, alongside emerging technologies such as quantum computing, 6G, and AI RAN; it also markets its solutions through government channels including Tradewinds, ARI, and Platform One, and in partnership with companies such as NVIDIA, AWS, and Shield AI. A growing part of its opportunity comes from transforming technical expertise into scalable products, such as the Vellox cybersecurity suite and the Ranger product, and from integrating advanced technologies into defense, intelligence, space, and civil-agency missions.

In Q1 of fiscal year 2027, revenue declined 4.2% year over year to $2.8 billion, and revenue excluding billable expenses declined 3.8%. Gross profit according to EDGAR data was approximately $1.5 billion, equivalent to a gross margin of about 53.6%, while net income was $198 million and GAAP diluted earnings per share were $1.63. On an adjusted basis, EBITDA was approximately $334 million at a margin of 11.9%, up 130 basis points, and adjusted diluted earnings per share increased 22% to $1.81, benefiting from a $19 million pre-tax unrealized gain on a venture investment.

The business mix showed two diverging paths in Q1 of fiscal year 2027: the National Security portfolio grew 1% year over year, while the Civil portfolio declined 16% due to the completion of large contracts, fewer new program starts, and the transition of some recompete wins to smaller scopes and shorter durations. Meanwhile, the company generated $261 million in free cash flow, total backlog exceeded $39 billion, up 3%, and funded backlog increased 15% to $4.7 billion; these indicators support management's expectation that National Security will drive growth during the remainder of fiscal year 2027.

What's Driving the Stock

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

Funded backlog increased 15% year over year to $4.7 billion in Q1 of fiscal year 2027, and the book-to-bill ratio was 1.5 times for the quarter and 1.1 times for the trailing twelve months, providing a stronger business base for converting funding into revenue.
  • Demand strength is concentrated in National Security, where funded backlog increased 23% and revenue grew 1% in Q1 of fiscal year 2027; management continues to expect this portfolio to grow at a mid-single-digit rate during fiscal year 2027, with more pronounced acceleration in the second half.
  • Cybersecurity represents a defined growth pillar through the Vellox suite for agentic threats and the Ranger product, which helps organizations detect and remediate vulnerabilities at AI speed; management said on July 24, 2026, that customer engagement is high and concern about agentic cyberattacks is translating into demand across government and commercial markets.
  • The $2.7 billion eMAPS 3 contract, which management described as the largest contract in Booz Allen's history, provides tangible evidence of demand for artificial intelligence capabilities in National Security missions. The company also announced in Q1 of fiscal year 2027 its largest pure-play quantum computing win and an AI RAN-related contract to provide 6G capabilities for edge missions.
  • Booz Allen expects to close the acquisition of Ultra I&C Mission Solutions in Q2 of fiscal year 2027, adding products in command-and-control software, rugged edge computing, and encryption management. Management stated that Ultra's business is delivering strong double-digit growth and EBITDA margins above 20%, but it has not included the transaction's impact in fiscal year 2027 guidance pending closing.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Demand indicators include total backlog exceeding $39 billion, funded backlog of $4.7 billion, and a book-to-bill ratio of 1.5 times in Q1 of fiscal year 2027, without an exceptional pull-forward of funding from later periods, according to management's clarification.
    • +Despite the revenue decline, adjusted EBITDA margin increased 130 basis points to 11.9%, and adjusted diluted earnings per share rose 22% to $1.81 in Q1 of fiscal year 2027, demonstrating the ability of improved contract execution and an early shift to outcomes-based pricing to support profitability.
    • +The company has defined growth drivers rather than merely broad bets on artificial intelligence, including Vellox, Ranger, the $2.7 billion eMAPS 3 contract, its largest pure-play quantum computing win, and an AI RAN contract linked to 6G capabilities.
    • +Free cash flow of $261 million and total liquidity of $2 billion at the end of Q1 of fiscal year 2027 provided flexibility to fund acquisitions, investments, and capital returns; the company distributed $123 million through cash dividends and share repurchases during the quarter.

    ▼ Selling Case6 pts

    • −The Civil portfolio declined 16% year over year in Q1 of fiscal year 2027, and management expects another double-digit sequential decline in Q2 due to contract completions and recompete wins transitioning to smaller scopes; it also expects the Civil portfolio to decline at a high-single-digit rate over fiscal year 2027.
    • −Booz Allen's total revenue declined 4.2% in Q1 of fiscal year 2027, while National Security growth of 1% was insufficient to offset the decline in Civil business, and the return to growth remains dependent on accelerating the execution of new business in the second half of the fiscal year.
    • −Management expects a margin of approximately 11% for fiscal year 2027, implying a decline from the first-quarter margin of 11.9% during the remainder of the year, particularly in Q2, due to the completion of high-margin Civil programs and the deferral of some investment spending to later periods.
    • −The pace of business depends on government funding and procurement; management warned on July 24, 2026, that the midterm election year and the paths of the NDAA, continuing resolution, reconciliation, and supplemental funding could create uncertainty, while procurement reforms may temporarily delay contract awards as customers transition to fixed-price contracts.
    • −Expanding fixed-price contracts could increase returns when execution is strong, but it transfers more cost and execution risk to Booz Allen, while management is still not prepared to specify the share this contract type will reach. This is compounded by a direct operational constraint, as headcount declined 7% and the company was behind in hiring personnel with the security clearances needed to accelerate National Security work.
    • −Net insider activity during the three months ended August 13, 2026, was approximately negative 36,544.48, with one sale and no purchases, a weak standalone signal because insider sales may be prearranged unless the data discloses otherwise.

    Valuation

    The average analyst price target is $89.71, compared with a wide range of $65 to $140, while the consensus rates the stock a “Buy”; the average target is below the 52-week range high of $110.55, while the highest target exceeds that high. A reliable price-to-earnings ratio is not available in the data, so the valuation assessment is based on the dispersion of targets and on the ability of National Security growth and improving profitability to offset Civil contraction and expected margin pressure during the remainder of fiscal year 2027.

    BuyAnalyst target: $89.71(+18.2%)

    Figures in the text are as of 2026-08-29; the live price is shown at the top of the page.

    FAQ

    What drove BAH's results in Q1 of fiscal year 2027?

    Revenue was $2.8 billion in Q1 of fiscal year 2027, down 4.2% year over year, reflecting the divergence between 1% growth in National Security and a 16% decline in Civil. Net income according to EDGAR was approximately $198 million, and earnings per share were $1.63. On an adjusted basis, EBITDA margin increased to 11.9%, and adjusted diluted earnings per share rose 22% to $1.81, with a contribution from a $19 million pre-tax unrealized gain on a venture investment.

    Why is Booz Allen's Civil business declining?

    Civil revenue declined 16% year over year in Q1 of fiscal year 2027 due to the completion of some large contracts and fewer new programs starting after contract awards slowed in the previous year. Some contracts that the company successfully renewed also became smaller in scope and shorter in duration. Management expects another double-digit sequential decline in Q2 of fiscal year 2027, followed by a gradual easing of these pressures in the second half, with an annual high-single-digit decline in Civil.

    How does BAH benefit from artificial intelligence and cybersecurity?

    Booz Allen is developing the Vellox suite of agentic cybersecurity products and launched Ranger to help customers detect and remediate vulnerabilities at AI speed. It has also built a multi-agent system to improve intelligence collection and coordinate missions among sensors, and it integrates artificial intelligence with edge computing in environments with limited connectivity and power. In Q1 of fiscal year 2027, the $2.7 billion eMAPS 3 contract, the largest in the company's history according to management, indicated the scale of demand for these capabilities in National Security.

    What is the significance of the Ultra I&C Mission Solutions acquisition for BAH stock?

    Booz Allen expects to close the transaction in Q2 of fiscal year 2027 and has not included Ultra's impact in its full-year guidance pending closing. Ultra adds products in command and control, rugged edge computing, and encryption management, complementing Booz Allen's defense technology portfolio. Management said on July 24, 2026, that Ultra's business is delivering strong double-digit growth and EBITDA margins above 20%, but it did not disclose a specific revenue run rate for the transaction.

    Is the backlog sufficient to support BAH's growth in fiscal year 2027?

    Total backlog exceeded $39 billion at the end of Q1 of fiscal year 2027, up 3% year over year, and funded backlog increased 15% to $4.7 billion. The book-to-bill ratio was 1.5 times during the quarter, while National Security funded backlog increased 23%. Nevertheless, management maintained its fiscal year 2027 guidance due to uncertainty surrounding funding and contract awards and expects acceleration to be concentrated in the second half.

    What are BAH's main risks during the remainder of fiscal year 2027?

    The clearest operational risk is continued contraction in Civil, with another double-digit sequential decline expected in Q2 of fiscal year 2027. Management also expects the margin to decline from 11.9% in the first quarter to approximately 11% for the full year due to the completion of high-margin programs and deferred investment spending. The government's transition to fixed-price contracts, uncertainty related to congressional funding paths, and difficulty hiring personnel with security clearances add risks to contract timing and the pace of backlog conversion into revenue.